Pamela Wedel
Career history of Pamela Wedel
Former positions of Pamela Wedel
Companies | Position | Start | End |
---|---|---|---|
SPRUCE BIOSCIENCES, INC. | Chief Operating Officer | - | - |
Corporate Officer/Principal | - | 2022-10-10 | |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - | - |
Training of Pamela Wedel
San Diego State University | Undergraduate Degree |
Statistics
International
United States | 4 |
Operational
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SPRUCE BIOSCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Pamela Wedel
- Experience